The Research Report on "Cardiac Mapping Market by Product (Contact Mapping Systems (Electroanatomical Mapping, Basket Catheter Mapping), Non-contact Mapping Systems), Indication (Atrial Fibrillation, Atrial Flutter, AVNRT), Region - Global Forecast to 2024", is expected to reach USD 2.1 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.7%.

The Growth in the cardiac mapping industry is driven primarily by factors such as new entrants in the market, growing investments, funds, and grants, increasing incidence of target diseases, and growth in the geriatric population.

Recent Developments;

- In 2019, Acutuc medical partnered with Peerbridge Health, US. Under the partnership, Peerbridge Health offered its advanced ambulatory ECG—Peerbridge Cor that has been cleared to detect up to 26 different arrhythmias to be used with the AcQMap System.

- In 2018, Royal Philips acquired EPD Solutions, Israel, an innovator in image-guided procedures for cardiac arrhythmias.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=89853405

Industry Segmentation In Detailed:

The contact cardiac mapping segment is projected to grow at the highest rate during the forecast period
By product, the cardiac mapping market is segmented into contact cardiac mapping (electroanatomical mapping, basket catheter mapping, traditional endocardial mapping) and non-contact cardiac mapping. The contact cardiac mapping segment is expected to witness the fastest growth during the forecast period. Advantages offered by contact cardiac mapping, such as detection of the precise locations of mapping and ablation catheters in a three-dimensional environment, also with multi-electrode basket catheter, recording just a few beats might be enough to uncover the arrhythmia circuit; these factors are increasing its adoption. Consequently, the demand for cardiac mapping devices for diagnosing complex arrhythmias is also growing.

Atrial fibrillation held the largest share of the cardiac mapping systems market in 2019

Cardiac mapping is used widely for the identification, characterization, and localization of an arrhythmia. The cardiac mapping systems indication market is segmented into atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT), other arrhythmias. The atrial fibrillation segment held the largest share of the market in 2019, a trend that is expected to continue during the forecast period. The large share of this segment can primarily be attributed to the rising incidences of AF throughout the globe.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=89853405

Leading Key Players and Analysis:

The major players operating in the cardiac mapping market include Biosense Webster (US), Abbott (US), and Boston Scientific Corporation (US). The other players in this market include Medtronic (Ireland), MicroPort Scientific Corporation (China), EP Solutions SA (Switzerland), Acutus Medical (US), Koninklijke Philips N.V. (Royal Philips) (Netherlands), Lepu Medical (China), BIOTRONIK (Germany), AngioDynamics (US), BioSig Technologies (US), APN Health (US), CoreMap (US), Kardium (Canada), Catheter Precision (US), and Epmap-System (Germany).

Biosense Webster (US) held the dominant position in the cardiac mapping market in 2018. The large share of this company can be attributed to its strong suite of cardiac mapping systems, software, and catheters. The company provides products mainly targeted at the diagnosis and treatment of several cardiac arrhythmias, such as atrial fibrillation. Moreover, the firm has a strong geographic presence in all regions of the world. The company focuses on product launches to create a strong foothold in the market. In 2019, Biosense introduced the CARTONET, a cloud-based networking and data analytics software solution.

Geographical Analysis in Detailed:

North America is expected to dominate the global cardiac mapping industry in 2019, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high growth in this region can be attributed to the large population, increasing geriatric population, the growing incidence of chronic diseases, rising healthcare spending, healthcare reforms for infrastructural development, and growing demand for advanced technologies.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=89853405